Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ABCA1. The gatekeeper for eliminating excess tissue cholesterol.

J F Oram1, R M Lawn

  • 1Department of Medicine, Box 356426, 1959 NE Pacific Pl., University of Washington, Seattle, WA 98195-6426, USA. joram@u.washington.edu

Journal of Lipid Research
|August 3, 2001
PubMed
Summary

The ATP-binding cassette transporter ABCA1 is crucial for removing excess cholesterol from cells, protecting against atherosclerosis. Its function is key to maintaining healthy high-density lipoprotein (HDL) levels and preventing cardiovascular disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoprotein(a) and atherogenesis.

Trends in cardiovascular medicine·2011
Same author

Sterol efflux mediated by endogenous macrophage ApoE expression is independent of ABCA1.

Arteriosclerosis, thrombosis, and vascular biology·2001
Same author

Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus.

The Journal of biological chemistry·2001
Same author

ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol.

The Journal of biological chemistry·2001
Same author

Expression monitoring using cDNA microarrays. A general protocol.

Methods in molecular biology (Clifton, N.J.)·2001
Same author

Functional analysis of the chimpanzee and human apo(a) promoter sequences: identification of sequence variations responsible for elevated transcriptional activity in chimpanzee.

The Journal of biological chemistry·2001

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Science

Background:

  • High-density lipoprotein (HDL) facilitates reverse cholesterol transport, potentially preventing atherosclerosis.
  • The ATP-binding cassette transporter ABCA1 initiates reverse cholesterol transport by moving cholesterol and phospholipids to apolipoproteins.

Purpose of the Study:

  • To elucidate the role of ABCA1 in cholesterol metabolism and cardiovascular disease.
  • To understand the impact of ABCA1 mutations and activity on HDL levels and atherosclerosis.

Main Methods:

  • Studied Tangier disease (TD) heterozygotes to assess ABCA1 activity's impact on HDL and cardiovascular disease (CVD).
  • Investigated drug-induced ABCA1 modulation in mice to observe effects on cholesterol clearance and absorption.

Related Experiment Videos

Main Results:

  • ABCA1 mutations cause Tangier disease, a condition marked by cholesterol accumulation in macrophages and atherosclerosis.
  • ABCA1 activity significantly influences plasma HDL levels and CVD susceptibility.
  • Inducing ABCA1 in mice enhanced cholesterol clearance and reduced intestinal cholesterol absorption.

Conclusions:

  • ABCA1 acts as a primary regulator of cellular cholesterol elimination, impacting overall cholesterol metabolism.
  • ABCA1 plays a critical role in protecting against cardiovascular disease by managing tissue cholesterol levels.